BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22985665)

  • 21. Autoantibodies in idiopathic inflammatory myopathy: an update on clinical and pathophysiological significance.
    Mimori T; Imura Y; Nakashima R; Yoshifuji H
    Curr Opin Rheumatol; 2007 Nov; 19(6):523-9. PubMed ID: 17917530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated necrotizing myopathy associated with ANTI-PL12 antibody.
    Mehndiratta P; Mehta S; Manjila SV; Kammer GM; Cohen ML; Preston DC
    Muscle Nerve; 2012 Aug; 46(2):282-6. PubMed ID: 22806380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inflammatory Myopathy: When Electromyography and Autoantibodies Don't Help the Diagnosis.
    De Carvalho A; Filipe Couto L; Gonçalves F; Cotter J
    Cureus; 2024 Feb; 16(2):e53569. PubMed ID: 38445121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune-mediated necrotizing myopathy is characterized by a specific Th1-M1 polarized immune profile.
    Preuße C; Goebel HH; Held J; Wengert O; Scheibe F; Irlbacher K; Koch A; Heppner FL; Stenzel W
    Am J Pathol; 2012 Dec; 181(6):2161-71. PubMed ID: 23058368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leflunomide-Induced Immune-Mediated Necrotizing Myopathy in a Patient With Rheumatoid Arthritis: A Case Report.
    Salazar DM; Damani DN; Kositangool P; Ortiz MJ; Lavezo J; Dihowm F
    J Investig Med High Impact Case Rep; 2023; 11():23247096221150636. PubMed ID: 36661254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: Clinical features and treatment outcomes in a Chinese cohort.
    Hou Y; Liu M; Luo YB; Sun Y; Shao K; Dai T; Li W; Zhao Y; Yan C
    Neuromuscul Disord; 2019 Jan; 29(1):5-13. PubMed ID: 30579751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies.
    Suzuki S; Yonekawa T; Kuwana M; Hayashi YK; Okazaki Y; Kawaguchi Y; Suzuki N; Nishino I
    J Neuroimmunol; 2014 Sep; 274(1-2):202-8. PubMed ID: 25064497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical presentation of the idiopathic inflammatory myopathies.
    Yazici Y; Kagen LJ
    Rheum Dis Clin North Am; 2002 Nov; 28(4):823-32. PubMed ID: 12506774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and histological features of immune-mediated necrotising myopathy: A multi-centre South Australian cohort study.
    Day J; Otto S; Cash K; Limaye V
    Neuromuscul Disord; 2020 Mar; 30(3):186-199. PubMed ID: 32229165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Necrotizing Autoimmune Myopathy: A Rare Variant of Idiopathic Inflammatory Myopathies.
    Khan NAJ; Khalid S; Ullah S; Malik MU; Makhoul S
    J Investig Med High Impact Case Rep; 2017; 5(2):2324709617709031. PubMed ID: 28660228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
    Benveniste O; Drouot L; Jouen F; Charuel JL; Bloch-Queyrat C; Behin A; Amoura Z; Marie I; Guiguet M; Eymard B; Gilbert D; Tron F; Herson S; Musset L; Boyer O
    Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The physiology of inflammatory myopathies: an overview.
    Lundberg IE
    Acta Physiol Scand; 2001 Mar; 171(3):207-13. PubMed ID: 11412132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Biological therapy in idiopathic inflammatory myopathies].
    Bodoki L; Nagy-Vincze M; Griger Z; Péter A; András C; Dankó K
    Orv Hetil; 2014 Jan; 155(1):3-10. PubMed ID: 24379090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idiopathic inflammatory myopathies.
    Dimachkie MM
    J Neuroimmunol; 2011 Feb; 231(1-2):32-42. PubMed ID: 21093064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Brazilian Society of Rheumatology recommendations on investigation and diagnosis of systemic autoimmune myopathies.
    de Souza FHC; de Araújo DB; Vilela VS; Simões RS; Bernardo WM; Frank TA; da Cunha BM; Shinjo SK
    Adv Rheumatol; 2019 Oct; 59(1):42. PubMed ID: 31601261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the gastrointestinal complications of myositis.
    Ebert EC
    Aliment Pharmacol Ther; 2010 Feb; 31(3):359-65. PubMed ID: 19886949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Necrotizing autoimmune myopathies].
    Petiot P; Choumert A; Hamelin L; Devic P; Streichenberger N
    Rev Neurol (Paris); 2013; 169(8-9):650-5. PubMed ID: 23999024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymyositis, dermatomyositis, and autoimmune necrotizing myopathy: clinical features.
    Khan S; Christopher-Stine L
    Rheum Dis Clin North Am; 2011 May; 37(2):143-58, v. PubMed ID: 21444016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic inflammatory myopathies.
    Limaye VS; Blumbergs P; Roberts-Thomson PJ
    Intern Med J; 2009 Mar; 39(3):179-190. PubMed ID: 19006486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic inflammatory myopathies in childhood: a brief review of 27 cases.
    Lorenzoni PJ; Scola RH; Kay CS; Prevedello PG; Espíndola G; Werneck LC
    Pediatr Neurol; 2011 Jul; 45(1):17-22. PubMed ID: 21723454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.